探讨盆腔廓清术围手术期情况及临床应用价值。

回顾性分析2019年6月至2021年10月收治的接受盆腔廓清术的9例患者临床资料，数据应用SPSS 25.0统计软件分析，计数资料以例或中位数描述，计量资料以（

（1）9例患者的中位年龄52岁［（36~69）岁］，中位住院时间34 d［（15~60）d］。其中2例为初治患者，7例为初治后复发的患者，从初治至复发的中位间隔时间为2.5年［（2~6）年］；（2）1例行前盆腔廓清术，2例行后盆腔廓清术，6例行全盆腔廓清术。其中4例手术在全腔镜下完成，5例手术中转开腹完成。手术平均时长为（6.4±0.6）h，术中平均出血量为［（555.6±95.9）］ml；（3）3例患者发生术后并发症，包括盆腔积液伴感染、肠梗阻及直肠瘘。术后随访时间截至2021年11月，中位总生存时间18个月［（1~26）个月］，中位无瘤生存时间9个月［（0~26）个月］，均无死亡病例。

盆腔廓清术后并发症发生率高，全腹腔镜下盆腔廓清术有其独有的优势，就短期随访来看，该术式的安全性及临床价值是可观的。

To investigate the perioperative situation and clinical application value of pelvic dissection.

The clinical data of 9 patients who underwent pelvic exocytosis from June 2019 to October 2021 were retrospectively analyzed. The count data were described as "cases" or as "median".

（1）The median age of the 9 patients was 52 years［（36~69）years］，and the median length of hospital stay was 34 days［（15~60）days］. The median interval from initial treatment to recurrence was 2.5 years［（2~6）years］.（2）Anterior pelvic dissection was performed in 1 patient，posterior pelvic dissection was performed in 2 patients，and total pelvic dissection was performed in 6 patients. Among them，4 cases were performed under full endoscopy and 5 cases were converted to open surgery. The average operation time was［（6.4±0.6）h］，and the average blood loss was［（555.6±95.9）ml］.（3）Postoperative complications occurred in 3 patients，including pelvic effusion with infection，intestinal obstruction and rectal fistula. The median overall survival time was 18 months［（1~26）months］and the median disease-free survival time was 9 months［（0~26）months］，and there was no death.

The incidence of complications after pelvic dissection is high. Total laparoscopic pelvic dissection has its own advantages. In terms of short-term follow-up，the safety and clinical value of this operation are considerable.